US-based medical device company MicroAire Surgical Instruments announced on Monday that it has acquired NEOSYAD, a French company that developed a breakthrough technology for adipose tissue engineering.
NEOSYAD has received EU MDR approval for its AdiMate device and Adipure single-use kit. AdiMate is designed to optimise operating times by integrating the infiltration, liposuction and adipose tissue preparation (lipofilling) functions due to its patented 'all-in-one' concept and integrated proprietary software.
The protocol integrated in the machine enables tissue purification in less than 10 minutes in a completely automatic way, while guaranteeing unmatched adipose tissue quality and viability.
Jerome Barrillon, MicroAire president, said: "We are thrilled to welcome the NEOSYAD team into the MicroAire family. Their expertise, innovative products and dedication to advancing adipose tissue technologies perfectly align with our mission to enable better patient outcomes and support plastic surgeons worldwide."
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke
Median Technologies secures funding for eyonis Lung Cancer Screening software
UCB launches 320 mg/2 mL single-injection administration option for BIMZELX (bimekizumab-bkzx) in US
Concept Medical reports first patient enrolled in MagicTouch SCB trial in peripheral artery disease
Creo Medical Group plc launches robotic-guided lung ablation procedures in the UK
Revvity and Element Biosciences partner to enhance neonatal sequencing for IVD testing
Implantica publishes real-world data supporting RefluxStop efficacy